4//SEC Filing
Theravance Biopharma, Inc. 4
Accession 0001179110-14-015387
$TBPHCIK 0001583107operating
Filed
Oct 9, 8:00 PM ET
Accepted
Oct 10, 7:04 PM ET
Size
5.7 KB
Accession
0001179110-14-015387
Insider Transaction Report
Form 4
BLUM LEONARD M
Sr VP, Chief Comm. Officer
Transactions
- Award
Share Option (Right to Buy)
2014-10-08+170,000→ 170,000 totalExercise: $22.00Exp: 2024-10-07→ Ordinary Shares (170,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable as follows: (a) with respect to the first 25% of the Company's shares subject to the option on October 1, 2015, subject to the optionee's continuous service through such date and (b) with respect to an additional 1/48th of the Company's shares subject to the option when the optionee completes each month of continuous service thereafter. The option shall be fully vested and exercisable on October 1, 2018 provided the optionee remains in continuous service with the Company through such date.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeoperating
IncorporatedCA
Related Parties
1- filerCIK 0001583107
Filing Metadata
- Form type
- 4
- Filed
- Oct 9, 8:00 PM ET
- Accepted
- Oct 10, 7:04 PM ET
- Size
- 5.7 KB